Search

Search Constraints

You searched for: Author/Creator Keezer, Kelly J.

Search Results

1. O1‐01‐03: GENETICALLY DIVERSE MOUSE MODELS OF ALZHEIMER'S DISEASE EXHIBIT DIFFERENTIAL MYELOID CELL RESPONSE AND NEURODEGENERATION. (1st July 2006)

2. O4‐09‐01: LEVERAGING MOUSE GENETIC DIVERSITY TO INVESTIGATE THE ROLE OF BRAIN MYELOID CELLS IN ALZHEIMER'S DISEASE. (1st July 2019)

4. P2‐045: THE MODEL‐AD CONSORTIUM PRECLINICAL TESTING PIPELINE: PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPHYLACTIC TREATMENT WITH LEVETIRACETAM IN THE 5XFAD MOUSE MODEL OF ALZHEIMER'S DISEASE. (1st July 2006)

6. P4‐028: CHARACTERIZING THE APOE4/TREM2*R47H MOUSE MODEL FOR LATE ONSET ALZHEIMER'S DISEASE. (1st July 2006)

7. P4‐079: CRITICAL EVALUATION OF THE PHARMACOKINETICS OF VERUBECESTAT IN AGED 5XFAD MICE. (1st July 2019)

8. Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study. Issue 1 (23rd August 2022)

9. Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice. Issue 1 (14th July 2022)